Karim Belhadj

Author PubWeight™ 25.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 2010 4.97
2 [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005 2.41
3 Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 2003 1.90
4 Clinical and biological features of t(4;14) multiple myeloma: a prospective study. Leuk Lymphoma 2011 1.52
5 Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study. Leuk Lymphoma 2012 1.40
6 Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA. Haematologica 2011 1.31
7 Gammadelta T-cell lymphomas. Semin Hematol 2003 1.13
8 Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010 1.09
9 Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood 2003 1.08
10 Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging. Radiology 2010 0.97
11 Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2006 0.95
12 Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003 0.90
13 Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 2012 0.89
14 Whole-Body Diffusion-weighted Imaging in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. Radiographics 2015 0.84
15 Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma. Haematologica 2013 0.84
16 Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study. Clin Cancer Res 2004 0.84
17 Atypical linear IgA dermatosis revealing angioimmunoblastic T-cell lymphoma. Arch Dermatol 2009 0.81
18 Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients. Eur Respir Rev 2013 0.79
19 A new case of signet ring cell carcinoma of the prostate. Clin Genitourin Cancer 2007 0.78
20 Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience. Radiology 2009 0.76
21 [Place of percutaneous nephrolithotomy in the treatment of staghorn stones, 83 cases]. Tunis Med 2010 0.75
22 [Nephroblastoma of the adult with intracaval extension]. Tunis Med 2011 0.75
23 [Intrasinusal bone marrow lymphoid infiltration]. Ann Pathol 2002 0.75